HLA class II TCR based bispecific T-cell engager (Yellowstone Biosciences)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameHLA class II TCR based bispecific T-cell engager (Yellowstone Biosciences)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT lymphocytes stimulantsHistocompatibility antigens class II modulatorsImmunostimulants

TargetsHistocompatibility antigens class II

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYellowstone Biosciences Ltd

China Registration ClassN/A

Develop Information

Active CompaniesYellowstone Biosciences Ltd

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A